Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelomonocytic, Chronic × olaparib × 90 days × Clear all

Sponsor

Conditions

Ovarian Neoplasms 23 Breast Neoplasms 21 Fallopian Tube Neoplasms 13 Triple Negative Breast Neoplasms 8 Prostatic Neoplasms 8 Neoplasms 6 Endometrial Neoplasms 6 Pancreatic Neoplasms 5 Neoplasm Metastasis 5 Stomach Neoplasms 3 Lymphoma, Non-Hodgkin 3 Glioma 3 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Solid Tumors 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Osteosarcoma 2 Multiple Myeloma 2 Metastatic Castration-resistant Prostate Cancer 2 Glioblastoma 2 Carcinoma, Ovarian Epithelial 2 Carcinoma 2 Xanthogranuloma, Juvenile 1 Wilms Tumor 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1

Interventions

Azacitidine 14 venetoclax 12 Specimen Handling 7 Decitabine 7 Biopsy 7 fludarabine 6 Injections 6 decitabine and cedazuridine drug combination 5 Stem Cell Transplantation 5 Cytarabine 5 Cyclophosphamide 5 fludarabine phosphate 4 Whole-Body Irradiation 4 Tacrolimus 3 Mycophenolic Acid 3 Hematopoietic Stem Cell Transplantation 3 Busulfan 3 sabatolimab 2 ruxolitinib 2 olutasidenib 2 enasidenib 2 cedazuridine 2 axatilimab 2 X-Rays 2 Vorinostat 2 Peripheral Blood Stem Cell Transplantation 2 Magnetic Resonance Spectroscopy 2 Lenalidomide 2 Idarubicin 2 Granulocyte Colony-Stimulating Factor 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡